Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 2:44 AM ET


Company Overview of Seaside Therapeutics, LLC

Company Overview

Seaside Therapeutics, LLC engages in the development of drugs to correct or improve the course of autism, fragile X syndrome, and other neurodevelopmental disorders. The company focuses on translating discoveries in neurobiology into therapeutics. Its products include STX209, a selective gamma-amino butyric acid type-B receptor agonist to serve STX209 to restore the normal balance at the synapse and correct abnormalities associated with autism and fragile X syndrome disorders; and STX107, a selective mGluR5 antagonist modulator. The company’s programs also include biomarker research, next generation mGlur5 negative allosteric modulator, and muscarinic acetylcholine receptor modulator. Seasid...

840 Memorial Drive

Cambridge, MA 02139

United States

Founded in 2005





Key Executives for Seaside Therapeutics, LLC

Co-Founder, Chief Executive Officer, President and Director
Age: 62
Scientific Founder and Advisor
Vice President of Manufacturing & Process Development
Vice President of Clinical Operations
Vice President of Clinical Development
Compensation as of Fiscal Year 2015.

Seaside Therapeutics, LLC Key Developments

Seaside Therapeutics, LLC Presents at 2014 Autism Investment Conference, Mar-04-2014 11:15 AM

Seaside Therapeutics, LLC Presents at 2014 Autism Investment Conference, Mar-04-2014 11:15 AM. Venue: Bently Reserve, 301 Battery St, San Francisco, CA 94111, United States. Speakers: Randall L. Carpenter, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Valeant Pharmaceuticals North America LLC United States
Schwarz Pharma Inc. United States
Pure Essence Laboratories, Inc. United States
LSK BioPartners, Inc. United States
Bryce Rx Laboratories, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Seaside Therapeutics, LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at